Immunology market size | Industry Trends & Forecast 2025

Q: How does 6W market outlook report help businesses in making decisions?

6W monitors the market across 60+ countries Globally, publishing an annual market outlook report that analyses trends, key drivers, Size, Volume, Revenue, opportunities, and market segments. This report offers comprehensive insights, helping businesses understand market dynamics and make informed decisions.

Q: Do you also provide customisation in the market study?

Yes, we provide customisation as per your requirements. To learn more, feel free to contact us on sales@6wresearch.com

Code: MTA10041

Publication Date: Oct 2025

What is the size of Immunology Market?

According to 6Wresearch internal database and industry insights, the Global Immunology Market was valued at USD 30000 Billion in 2024 and is expected to reach USD 53000 Billion by 2031, growing at a compound annual growth rate of 6.90% during the forecast period (2025-2031).

The growing prevalence of autoimmune and inflammatory diseases, the progress in biologics and monoclonal antibody treatment areas, increasing research and development (R&D) investment, and growing investment in precision immunotherapy and vaccine research is driving growth in the operational space.

Growth Factors for Immunology Industry

The rising number of autoimmune diseases, such as rheumatoid arthritis, lupus, etc.
Increasing use of biologics and biosimilars for targeted immune modulation
Increasing R&D investments in the areas of immuno-oncology and chronic inflammatory diseases
Increasing utilisation of relevant immunology diagnostic and treatment methodologies
Increased regulatory support and funding for immunology vaccine and antibody innovation

Immunology Market Trends

Market Trends in Immunology include the increased focus on personalised Immunotherapeutics and advanced biologics as treatment modalities. Major drug companies are involved in developing next-generation antibody therapies, targeted cytokine inhibitors, and immune checkpoint therapies. There is increasing use of genomics and proteomics in immunology research, improving our understanding of disease and, therefore, our treatments. There continues to be an increase in partnerships between biotech start-ups and research delivery and research support institutions for immunology.

View Main Report

Schedule Analyst Call

Emerging Developments in the Immunology Market

The Immunology Market developments include rapid advancements in cell-based therapies, such as CAR-T and TCR-T technologies. Companies are investing heavily in next-generation immunomodulatory drugs and biosimilars to enhance treatment accessibility. Innovations in vaccine development platforms are driving preventive care expansion. Moreover, digital health integration and AI-based immune profiling are improving therapeutic precision. These advancements are transforming the immunology landscape by enhancing treatment efficacy and patient outcomes.